` 476830 (Rznomics Inc) vs KOSPI 200 Comparison - Alpha Spread

R
476830
vs
K
KOSPI 200

Over the past 12 months, Rznomics Inc has underperformed KOSPI 200, delivering a return of -67% compared to KOSPI 200's +153% growth.

Stocks Performance
476830 vs KOSPI 200

Loading...
476830
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
476830 vs KOSPI 200

Performance Gap Between 476830 and KOSPI200
LOCKED
Unlock

Performance By Year
476830 vs KOSPI 200

Loading...
476830
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Rznomics Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Rznomics Inc
Glance View

Market Cap
846B KRW
Industry
Biotechnology

Rznomics, Inc. is a biotechnology company, which engages in the development of ribonucleic acid (RNA) based gene therapies for cancers and intractable diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2025-12-18. The Company’s main products include RNA editing enzyme-based gene therapies, self-circularized RNA structures, and RNA platform technologies. The firm sells its products in domestic and overseas markets.

Intrinsic Value
Not Available
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett